Nivolumab immunotherapy safe and feasible during chemo-radiotherapy for advanced head and neck cancer

Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiotherapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers.
PR Newswire